Client’s Testimonial:
“I received the approval notice yesterday. Thank you very much for helping me…”
On February 26th, 2016, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Researcher in the Field of Pharmaceutics (Approval Notice).
General Field: Pharmaceutics
Position at the Time of Case Filing: Postdoctoral Researcher
Country of Origin: China
Service Center: Texas Service Center (TSC)
State of Residence at the Time of Filing: Texas
Approval Notice Date: February 26th, 2016
Processing Time: 18 days (Premium Processing requested)
Case Summary:
A gifted postdoctoral researcher from China secured the legal services of North America Immigration Law Group (WeGreened.com) to file an EB-1A (Alien of Extraordinary Ability) petition on his behalf. Before taking on the case, we carefully went through our client’s credentials to determine if he qualified to file his petition under this category. We discovered that our client met three of the 10 requirements set in place by the USCIS, and upon activation of the contract, we immediately got to work on his EB-1A petition packet. The three requirements he met are as follows:
- Authorship of scholarly articles
We documented our client’s 12 peer-reviewed articles and one first-authored book chapter. We established that our client’s published work –particularly his articles that appeared in high ranking journals—are recognized as rare accomplishments achieved by only the best scientists in the field.
- Judge the work of others
Our client has extended his valuable insights to others in his field by conducting 37 peer reviews for more than half a dozen high impact scientific journals. This showcases the value of his opinions and his high standing in the field.
- Original Contributions
When we filed his EB-1A petition, our client’s work had gathered 235 citations. This is another demonstration of the value of our client’s findings to other researchers who are also advancing the field of pharmaceutics.
Besides providing the USCIS with the aforementioned evidence, we included recommendation letters contributed by other experts in the field to support our EB-1A petition. Six experts agreed to contribute letters, one of whom wrote, in part, “[Client] has made much concrete advancement in this area of research and I and many other researchers have recognized the importance of his work to not only our field, but to the quality of medical care in general. I think it is necessary that the U.S. secure his position in the country.” Additional data such as summaries of our client’s research on pharmacokinetics, the design of drug delivery systems, and the preparation of novel anti-cancer drugs were also incorporated into our well-worded petition packet. They served as evidence that our client’s research is essential to public health as well as the health care sector in the United States.
Eight days after our legal team filed the EB-1A petition on our client’s behalf, he decided to upgrade his case to Premium Processing. This option allows for rapid adjudication (15 days as opposed to 4-9 months). 10 days after we upgraded the case, we received a notice from the USCIS informing us that they had approved our client’s EB-1A petition. We congratulate our client on this milestone and wish him the best with his continued research ventures.